Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 187

1.

Successful active immunization using a hepatitis B virus vaccination protocol for a recipient with hepatitis B core antibody-positive liver graft.

Ohno Y, Mita A, Ikegami T, Masuda Y, Urata K, Nakazawa Y, Kobayashi A, Miyagawa S.

Transplant Proc. 2014 Apr;46(3):721-5. doi: 10.1016/j.transproceed.2013.12.005.

PMID:
24767333
2.

High-titer antibody to hepatitis B surface antigen before liver transplantation can prevent de novo hepatitis B infection.

Su WJ, Ho MC, Ni YH, Chen HL, Hu RH, Wu YM, Chang MH, Lee PH.

J Pediatr Gastroenterol Nutr. 2009 Feb;48(2):203-8. doi: 10.1097/MPG.0b013e3181819ad4.

PMID:
19179883
4.

Prevention of hepatitis B virus infection from hepatitis B core antibody-positive donor graft using hepatitis B immune globulin and lamivudine in living donor liver transplantation.

Suehiro T, Shimada M, Kishikawa K, Shimura T, Soejima Y, Yoshizumi T, Hashimoto K, Mochida Y, Maehara Y, Kuwano H.

Liver Int. 2005 Dec;25(6):1169-74.

PMID:
16343068
5.

Active immunization against de novo hepatitis B virus infection in pediatric patients after liver transplantation.

Chang SH, Suh KS, Yi NJ, Choi SH, Lee HJ, Seo JK, Lee KU.

Hepatology. 2003 Jun;37(6):1329-34.

PMID:
12774011
6.

Use of hepatitis B core antibody-positive donors in orthotopic liver transplantation.

Holt D, Thomas R, Van Thiel D, Brems JJ.

Arch Surg. 2002 May;137(5):572-5; discussion 575-6.

PMID:
11982471
7.

De novo hepatitis b prophylaxis with hepatitis B virus vaccine and hepatitis B immunoglobulin in pediatric recipients of core antibody-positive livers.

Lee S, Kim JM, Choi GS, Park JB, Kwon CH, Choe YH, Joh JW, Lee SK.

Liver Transpl. 2016 Feb;22(2):247-51. doi: 10.1002/lt.24372.

8.

Active immunization to prevent de novo hepatitis B virus infection in pediatric live donor liver recipients.

Lin CC, Chen CL, Concejero A, Wang CC, Wang SH, Liu YW, Yang CH, Yong CC, Lin TS, Jawan B, Cheng YF, Eng HL.

Am J Transplant. 2007 Jan;7(1):195-200.

9.

Prevention of de novo hepatitis B virus infection in living donor liver transplantation using hepatitis B core antibody positive donors.

Chen YS, Wang CC, de Villa VH, Wang SH, Cheng YF, Huang TL, Jawan B, Chiu KW, Chen CL.

Clin Transplant. 2002 Dec;16(6):405-9.

PMID:
12437618
10.

Prevention of de novo hepatitis B infection from HbcAb-positive donors in living donor liver transplantation.

Lee KW, Lee DS, Lee HH, Kim SJ, Joh JW, Seo JM, Choe YH, Lee SK.

Transplant Proc. 2004 Oct;36(8):2311-2.

PMID:
15561233
11.

Risk of de novo hepatitis in liver recipients from hepatitis-B core antibody-positive grafts - a systematic analysis.

Skagen CL, Jou JH, Said A.

Clin Transplant. 2011 May-Jun;25(3):E243-9. doi: 10.1111/j.1399-0012.2011.01409.x. Epub 2011 Feb 16.

PMID:
21323735
12.

Prevention of de novo hepatitis B with adefovir dipivoxil in recipients of liver grafts from hepatitis B core antibody-positive donors.

Chang MS, Olsen SK, Pichardo EM, Heese S, Stiles JB, Abdelmessih R, Verna EC, Guarrera JV, Emond JC, Brown RS Jr.

Liver Transpl. 2012 Jul;18(7):834-8. doi: 10.1002/lt.23429.

13.

Active vaccination to prevent de novo hepatitis B virus infection in liver transplantation.

Lin CC, Yong CC, Chen CL.

World J Gastroenterol. 2015 Oct 21;21(39):11112-7. doi: 10.3748/wjg.v21.i39.11112. Review.

14.

Lamivudine monoprophylaxis for de novo HBV infection in HBsAg-negative recipients with HBcAb-positive liver grafts.

Vizzini G, Gruttadauria S, Volpes R, D'Antoni A, Pietrosi G, Filì D, Petridis I, Pagano D, Tuzzolino F, Santonocito MM, Gridelli B.

Clin Transplant. 2011 Jan-Feb;25(1):E77-81. doi: 10.1111/j.1399-0012.2010.01329.x. Epub 2010 Oct 11.

PMID:
21039887
15.

Kidney transplantation from hepatitis B virus core antibody-positive donors: prophylaxis with hepatitis B immunoglobulin.

Veroux M, Corona D, Ekser B, Giaquinta A, Tallarita T, De Martino C, Gentile F, Virgilio C, Gagliano M, Fiamingo P, Veroux P.

Transplant Proc. 2011 May;43(4):967-70. doi: 10.1016/j.transproceed.2011.01.155.

PMID:
21620027
16.

Transplantation of livers from hbc Ab positive donors into HBc Ab negative recipients: a strategy and preliminary results.

Loss GE, Mason AL, Blazek J, Dick D, Lipscomb J, Guo L, Perrillo RP, Eason JD.

Clin Transplant. 2001;15 Suppl 6:55-8.

PMID:
11903388
17.

Use of renal allografts from donors positive for hepatitis B core antibody confers minimal risk for subsequent development of clinical hepatitis B virus disease.

Madayag RM, Johnson LB, Bartlett ST, Schweitzer EJ, Constantine NT, McCarter RJ Jr, Kuo PC, Keay S, Oldach DW.

Transplantation. 1997 Dec 27;64(12):1781-6.

PMID:
9422420
18.

Risks and treatment strategies for de novo hepatitis B virus infection from anti-HBc-positive donors in pediatric living donor liver transplantation.

Dong C, Gao W, Ma N, Sun C, Zheng WP, Wang K, Shen ZY.

Pediatr Transplant. 2017 Mar;21(2). doi: 10.1111/petr.12854. Epub 2016 Dec 9.

PMID:
27933716
19.

Use of hepatitis B core antibody-positive liver allograft in hepatitis C virus-positive and -negative recipients with use of short course of hepatitis B immunoglobulin and Lamivudine.

Jain A, Orloff M, Abt P, Kashyap R, Mohanka R, Lansing K, Kelley M, Bozorgzadeh A.

Transplant Proc. 2005 Sep;37(7):3187-9.

PMID:
16213345
20.

Safe use of livers from donors with positive hepatitis B core antibody.

Manzarbeitia C, Reich DJ, Ortiz JA, Rothstein KD, Araya VR, Munoz SJ.

Liver Transpl. 2002 Jun;8(6):556-61.

Supplemental Content

Support Center